F. Amair-Pinedo

发表

Simultaneous electrophoretic analysis of proteins of very high and low molecular mass using Tris‐acetate polyacrylamide gels

M. Cubillos-Rojas, J. L. Rosa, F. Ventura, 2010, Electrophoresis.

Tris-Acetate Polyacrylamide Gradient Gels for the Simultaneous Electrophoretic Analysis of Proteins of Very High and Low Molecular Mass.

M. Cubillos-Rojas, J. L. Rosa, F. Ventura, 2018, Methods in molecular biology.

Tris-acetate polyacrylamide gradient gels for the simultaneous electrophoretic analysis of proteins of very high and low molecular mass.

M. Cubillos-Rojas, J. L. Rosa, F. Ventura, 2012, Methods in molecular biology.

Progressive Purkinje Cell Degeneration in tambaleante Mutant Mice Is a Consequence of a Missense Mutation in HERC1 E3 Ubiquitin Ligase

C. Sotelo, T. Serikawa, J. Guénet, 2009, PLoS genetics.

The Treatment Landscape and New Opportunities of Molecular Targeted Therapies in Gastroenteropancreatic Neuroendocrine Tumors

F. Amair-Pinedo, I. Matos, J. Capdevila, 2017, Targeted Oncology.

266P MEN1611, a PI3K inhibitor, combined with trastuzumab (T) ± fulvestrant (F) for HER2+/PIK3CA mutant (mut) advanced or metastatic (a/m) breast cancer (BC): Safety and efficacy results from the ongoing phase Ib study (B-PRECISE-01)

M. Piccart, H. Wildiers, G. Curigliano, 2021, Annals of Oncology.

The E3 Ubiquitin Protein Ligase HERC2 Modulates the Activity of Tumor Protein p53 by Regulating Its Oligomerization*

M. Cubillos-Rojas, J. L. Rosa, F. Ventura, 2014, The Journal of Biological Chemistry.

347P Results of the phase Ib dose escalation study of MEN1611, a PI3K inhibitor, combined with trastuzumab (T) ± fulvestrant (F) for HER2+/PIK3CA mutant (mut) advanced or metastatic (a/m) breast cancer (BC)

M. Piccart, H. Wildiers, P. Tassone, 2020 .

Determinants of concordance in clinically relevant genes (CRG) from synchronously acquired tumor biopsies (tBx) and ctDNA in metastatic breast cancer (MBC).

P. Nuciforo, R. Dienstmann, E. Zamora, 2019, Journal of Clinical Oncology.